Artificial intelligence has driven impressive advances in oncology, helping researchers and clinicians better understand how tumors develop and how to target them with greater precision. BioTuring, a biotechnology startup and member of the NVIDIA Inception program, has unveiled a new AI model that maps cancerous tumors at the cellular level.
This innovative approach allows researchers to visualize cellular interactions in real time, helping to identify new therapeutic targets. Using NVIDIA H100 Tensor Core GPUs and specialized libraries, this technology accelerates the analysis and simulation processes, enabling scientists to create more effective and personalized therapies.
The Role of AI in Personalizing Treatments In addition to enabling more accurate diagnoses, AI is helping to develop more effective drugs by analyzing how killer T cells interact with tumors. With this technology, it is possible to strengthen each patient’s immune system to fight cancer in a personalized way.
At RISC, we believe that technology has the power to transform lives. That’s why we’re working with NVIDIA to bring these innovations to market and drive the evolution of medicine.
📌 Want to learn more about how AI can impact the healthcare industry?
Talk to us!
Related Posts
